Phospholipids' particles inhalation in therapy of asthma: randomized placebo-controlled trial

The prospective single-blind randomized placebo controlled study was performed. The aim of the study was to investigate the effectiveness and safety of phospholipids' particles inhalation in patients with bronchial asthma. The results obtained demonstrate the statistically significant improvements both in clinical status and lung function tests. No any clinically significant adverse events were registered.